Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:EME
NYSE:EMEConstruction

A Look At EMCOR Group’s (EME) Valuation After FTSE All World Index Inclusion

Index inclusion puts EMCOR Group (EME) on more investors’ radar EMCOR Group (EME) was added to the FTSE All-World Index in March 2026. This inclusion can attract fresh demand as index funds and institutional investors adjust their holdings. See our latest analysis for EMCOR Group. Despite a recent 1-day share price decline of 5.03% and a 30-day share price decline of 9.98% to US$726.31, EMCOR’s 1-year total shareholder return of 91.87% and 5-year total shareholder return of about 5.5x suggest...
NasdaqGS:BWIN
NasdaqGS:BWINInsurance

Share Buyback and Analyst Upgrade Could Be A Game Changer For Baldwin Insurance Group (BWIN)

In February 2026, Raymond James upgraded The Baldwin Insurance Group Inc. to a strong Buy rating after the company delivered its sixth consecutive year of leading industry organic growth, margin expansion, and robust adjusted diluted earnings per share. At the same time, Baldwin Insurance Group authorized a US$250,000,000 share repurchase program over the next 12 months, signaling management’s confidence in the business and capital allocation priorities. We’ll now examine how Baldwin...
SEHK:373
SEHK:373Consumer Finance

Assessing Allied Group (SEHK:373) Valuation After Its 2025 Profit Turnaround

What the earnings turnaround means for Allied Group shareholders Allied Group (SEHK:373) has just reported full year 2025 earnings, moving from a loss in 2024 to a net profit of HK$2,224.1 million on revenue of HK$17,324.8 million. This shift back into profit, after a consolidated loss attributable to owners of approximately HK$0.8 billion in 2024, is central to how you might now think about the stock, its risk profile, and its income potential. Management had flagged this improvement on...
NYSE:ELV
NYSE:ELVHealthcare

Evaluating Elevance Health (ELV) After Q4 Results And 2026 Earnings Target Update

Q4 Earnings Put Elevance Health (ELV) in Focus Elevance Health (ELV) moved back into the spotlight after reporting fourth quarter and full-year 2025 results, highlighting Medicaid and Medicare Advantage pressures alongside Health Benefits revenue growth and a 2026 adjusted EPS target of at least $25.50. See our latest analysis for Elevance Health. At a share price of US$294.25, Elevance Health has seen a 10.05% 1 month share price decline and a 16.94% year to date share price decline, while...
NYSE:KOF
NYSE:KOFBeverage

A Look At Coca Cola FEMSA (NYSE:KOF) Valuation After The Newly Approved 2026 Dividend Plan

Dividend decision and what it means for investors Coca-Cola FEMSA. de (NYSE:KOF) shareholders have approved a cash dividend of MXN 0.9675 per share for fiscal 2025, to be paid in four equal installments across April, July, October, and December 2026. Each payment will amount to MXN 0.241875 per share, or MXN 1.935 per KOF UBL unit. This provides investors with clear visibility on expected cash distributions through next year. See our latest analysis for Coca-Cola FEMSA. de. The dividend...
XTRA:HPHA
XTRA:HPHABiotechs

Heidelberg Pharma (XTRA:HPHA) FY 2025 Loss Deepens To €0.91 EPS Challenges Growth Narrative

Heidelberg Pharma FY 2025 earnings snapshot Heidelberg Pharma (XTRA:HPHA) has reported its FY 2025 results, with fourth quarter revenue of €5.5 million and a basic EPS loss of €0.46, while the latest trailing twelve month figures show total revenue of €6.9 million and a basic EPS loss of €0.91. Over recent periods, revenue has ranged from €0.05 million to €5.5 million per quarter, with quarterly basic EPS losses between €0.13 and €0.46. The latest figures keep the focus on how efficiently the...
NYSE:AFL
NYSE:AFLInsurance

Aflac Balances New Long Term Care Rider With Governance Scrutiny

Aflac (NYSE:AFL) has introduced a hybrid term life and long term care rider aimed at aging U.S. consumers. The company is responding to growing long term care needs with a product that blends life insurance coverage and potential long term care benefits. Activist shareholder John Chevedden has filed a proposal urging Aflac to separate the Chairman and CEO roles. Aflac’s board is recommending shareholders vote against the governance proposal at the upcoming annual meeting. Aflac, trading...
OM:EVO
OM:EVOHospitality

Assessing Evolution’s (OM:EVO) Valuation After The Board’s 2025 Dividend Cancellation Proposal

Dividend decision shifts focus to Evolution’s capital allocation Evolution (OM:EVO) has proposed that no dividend be distributed for 2025, marking a clear break from regular cash payouts and placing capital allocation and business priorities at the center of investor attention. This kind of dividend decision often matters most to income focused holders, since it can change the appeal of the shares compared with other options that still provide regular cash distributions. See our latest...
NYSE:CRCL
NYSE:CRCLSoftware

Circle Reverses USDC Wallet Blacklist Raising Questions For Investor Trust

Circle Internet Group rapidly reversed a recent decision to blacklist certain USDC wallets after sharp criticism from users and industry participants. The move has raised fresh questions about censorship risk, issuer control over stablecoins, and how far compliance actions can go before trust is affected. Investors and users are watching how Circle refines its approach to regulatory demands while keeping USDC perceived as a reliable settlement asset. Circle Internet Group (NYSE:CRCL) sits...
NasdaqGS:WFRD
NasdaqGS:WFRDEnergy Services

A Look At Weatherford International (WFRD) Valuation After Positive RBC Coverage And Ongoing Business Transformation

RBC Capital has initiated coverage of Weatherford International (WFRD) with a positive view, citing peer leading cash generation, strong returns, and what it sees as an attractive valuation during current industry supply disruptions. See our latest analysis for Weatherford International. Weatherford International’s share price has been volatile recently, with a 9.63% 7 day share price return offsetting a 10.22% 30 day share price decline. Its 1 year total shareholder return of 78.30% and very...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

Claude Mythos Leak Tests CrowdStrike’s Premium Cybersecurity Valuation And Moat

Leaked details of Anthropic's upcoming Claude Mythos AI model suggest powerful offensive cyber capabilities focused on security use cases. The leak has sparked concerns that AI driven cyber tools could outpace current defenses and pressure premium security platforms. CrowdStrike Holdings (NasdaqGS:CRWD) shares, recently at $392.62, have been caught in a sector wide selloff as investors reassess AI related cyber risks. For CrowdStrike, the news lands after a mixed stretch for shareholders,...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

A Look At PayPal Holdings (PYPL) Valuation As Regulatory Scrutiny Rises And PYUSD Expands Globally

PayPal Holdings (PYPL) sits at the intersection of fresh regulatory pressure and product expansion, as US regulators question its account practices while the company rolls out its PYUSD stablecoin across 70 markets worldwide. See our latest analysis for PayPal Holdings. The recent mix of regulatory warnings and new product launches has not yet translated into share price strength. A 90 day share price return of 24.63% decline and a 1 year total shareholder return of 34.01% decline point to...
NYSE:CF
NYSE:CFChemicals

CF Industries (CF) Is Up 5.6% After Index Exit And Severance Vote Fight Has The Bull Case Changed?

Recently, CF Industries Holdings was removed from the FTSE All-World Index and urged shareholders to vote against a proposal limiting large executive severance packages at its upcoming April 28, 2026 annual meeting. Together with an upbeat analyst reassessment tied to tight nitrogen markets, these developments highlight how corporate governance choices intersect with CF Industries’ positioning in global fertilizer and low-carbon ammonia markets. We’ll now examine how CF Industries’ index...
XTRA:IVU
XTRA:IVUSoftware

IVU Traffic Technologies (XTRA:IVU) Margin Slip To 8.8% Tests Bullish Growth Narratives

IVU Traffic Technologies FY 2025 results snapshot IVU Traffic Technologies (XTRA:IVU) has wrapped up FY 2025 with fourth quarter revenue of €49.8 million and basic EPS of €0.51. The trailing twelve months show revenue of €151.5 million and EPS of €0.77, setting the tone for the latest earnings update. Over recent periods, revenue has moved from €134.5 million to €151.5 million on a trailing basis, with EPS shifting from €0.69 to €0.77. This provides a clear view of how the top and bottom line...
XTRA:O4B
XTRA:O4BCapital Markets

OVB Holding (XTRA:O4B) Margin Compression To 1.9% Challenges Bullish Narratives

OVB Holding (XTRA:O4B) has wrapped up FY 2025 with fourth quarter revenue of €125.48 million, Basic EPS of about €0.21 and net income of €3.01 million, giving investors a clean snapshot of how the year closed. The company has seen quarterly revenue move from €110.92 million in Q4 2024 to €125.48 million in Q4 2025, while Basic EPS shifted from roughly €0.41 to €0.21 over the same period. This sets up a mixed picture on the income line and puts the focus squarely on how margins are holding...
NYSE:WST
NYSE:WSTLife Sciences

Is West Pharmaceutical Services (WST) Pricing Justified After Mixed Returns And Rich P/E Multiple

If you are wondering whether West Pharmaceutical Services is priced fairly or carrying a premium, the recent share performance gives an important starting clue before looking at the numbers behind it. The stock last closed at US$248.12, with returns of 3.2% over 7 days, 1.1% over 30 days, a 10.2% decline year to date, and a 10.1% gain over 1 year. This combination paints a mixed picture of recent sentiment. Recent coverage on West Pharmaceutical Services has focused on its role in...
SEHK:2126
SEHK:2126Biotechs

JW Cayman Therapeutics SEHK 2126 Loss Of C¥267m Tests Bullish Growth Narratives

JW (Cayman) Therapeutics (SEHK:2126) has reported its FY 2025 first half with revenue of C¥106.3 million and a basic EPS loss of C¥0.64, while trailing 12 month figures show revenue of C¥283.7 million against a net loss of C¥555.3 million. Over the past three reported halves, revenue has moved from C¥86.8 million in 1H 2024 to C¥71.4 million in 2H 2024 and then to C¥106.3 million in 1H 2025, with basic EPS losses ranging between C¥0.58 and C¥0.85 per share. For investors, the latest numbers...
NYSE:MSM
NYSE:MSMTrade Distributors

A Look At MSC Industrial Direct (MSM) Valuation After Recent Share Price Moves

Without a specific news announcement driving attention today, MSC Industrial Direct (MSM) still gives investors a lot to consider, including its US$3.8b in revenue and its recent mixed share price moves. See our latest analysis for MSC Industrial Direct. The recent 1-day share price decline of 2.63% to US$89.48 follows a 7-day gain of 2.99% and a 1-year total shareholder return of 15.93%, pointing to steady long-term momentum despite some near-term volatility. If this kind of industrial...
NYSE:NET
NYSE:NETIT

Cloudflare (NET) Valuation Check As Shares Slip Despite Strong Recent Momentum

Cloudflare stock snapshot and recent performance Cloudflare (NET) shares recently closed at US$210.13, with the stock showing a 3.6% decline over the past day and a 5.1% decline over the past week, while remaining positive over the month and past 3 months. See our latest analysis for Cloudflare. While Cloudflare’s share price has slipped in the past week, its 28.3% 1 month share price return and 77.2% 1 year total shareholder return suggest momentum has been strong over both shorter and...
NasdaqGS:ROIV
NasdaqGS:ROIVBiotechs

Should Roivant’s Moderna Settlement Shift Investor Focus to Pipeline Execution Risks for Roivant Sciences (ROIV)?

In March 2026, several banks, including Bernstein and JPMorgan, updated their views on Roivant Sciences after a global settlement with Moderna over lipid nanoparticle technology. These analyst actions suggest the settlement is shifting attention away from legal risk and toward Roivant’s upcoming clinical trial milestones in pulmonary hypertension and non-infectious uveitis. We’ll now examine how the Moderna settlement, seen as clearing a legal overhang, may influence Roivant’s existing...
NYSE:FMC
NYSE:FMCChemicals

Assessing FMC (FMC) Valuation After Annual Loss And Recent Share Price Recovery

FMC (FMC) has drawn attention after reporting annual revenue of US$3.47b alongside a net loss of US$2.20b. This has prompted investors to reassess how the agricultural sciences group is currently being valued. See our latest analysis for FMC. Despite the headline net loss, FMC’s recent share price performance has been firmer, with a 12.8% 1 month share price return and a 15.5% 3 month share price return. However, the 1 year total shareholder return of 61.4% remains deeply negative. If you are...
NasdaqGS:SHOP
NasdaqGS:SHOPIT

Is Shopify (SHOP) Quietly Becoming the Operating System for Global Enterprise Retail?

Transcosmos announced it had helped Wacoal roll out Shopify-based e-commerce sites across Vietnam, Hong Kong and Singapore, with Malaysia and the Philippines to follow, using a centralized Shopify Plus master site to cut costs and simplify local customization. This rollout highlights how Shopify’s platform is being used to standardize global brand governance while still enabling locally tailored operations, boosting efficiency and conversion for enterprise retailers in Asia. We’ll now...
NYSE:VG
NYSE:VGOil and Gas

Venture Global Edison Settlement Refocuses Calcasieu Pass Story On Europe

Venture Global (NYSE:VG) and Edison resolved their arbitration related to the Calcasieu Pass LNG project. The settlement includes a commercial agreement to supply additional LNG cargoes into Europe, with a focus on Italy. The resolution ends a prolonged legal dispute and adjusts the future commercial relationship between the two companies. Venture Global, an LNG exporter with a growing presence in transatlantic gas trade, now has one less legal overhang tied to its Calcasieu Pass project...
NYSE:CCK
NYSE:CCKPackaging

Crown Holdings Weighs New COO Appointment And Shareholder Rights Proposal

Crown Holdings (NYSE:CCK) has appointed Dr. John M. Rost as Executive Vice President and Chief Operating Officer, Asia Pacific and Transit Packaging. The company also received a shareholder proposal seeking the right for investors to act by written consent, ahead of its annual meeting. Crown Holdings, trading at $101.69, is drawing attention as it reshapes senior leadership around its Asia Pacific and Transit Packaging operations. The stock shows a 29.1% return over 3 years and a 14.5%...